Over the last thirty years, we’ve refined our understanding of MS. With each research study, another dot is added to our picture of the disease. It’s certainly not a straight…
At the Rocky Mountain MS Center we periodically survey people in the MS community to find out what they want from us. A frequent, frustrated response is, “A cure for…
Earlier this fall, PCORI (the Patient Centered Outcomes Research Institute) released a request for funding applications for comparative effectiveness studies of Multiple sclerosis (MS) disease modifying therapies (DMTs). This includes…
Untitled Document Support the MS Center The Rocky Mountain MS Center is a 501(c)(3) Charitable Organization, Federal ID number 84-0795455. We have been rated a Gold Participant by GuideStar Exchange, an independent…
We have an update for you regarding Ocrelizumab – the investigational disease modifying therapy that we have told you about over the past several months. Last week, the FDA…
https://youtu.be/79-neCtENZ8 Join the RMMSC’s Dr. Enrique Alvarez as he discusses the latest developments in MS research, including those presented at the 2016 ECTRIMS conference in Europe. If you were not…
Get Ready for Ski Season with Adaptive Ski Passes! The snow has started falling in the mountains and ski season is beginning here in the Rockies! If you are a…
Diane Kuehnast is swimming the English Channel many times over. But she avoids the cold, treacherous waters. Twice per week, Diane swims in the pools at the Englewood Recreation…
In this webinar, Dr. Teri Schreiner explores her specialty, the rare development of pediatric MS. While MS most often manifests in adults between 30 and 45, Dr. Schreiner treats cases in…
